ConductScience.org, home

Paper37218433

Effect of Vitamin D Supplementation on Graves' Disease: The DAGMAR Trial.

Grove-Laugesen D and 8 others. Thyroid, 2023. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Effect of Vitamin D Supplementation on Graves' Disease: The DAGMAR Trial. Papers, record 37218433. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37218433

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of Vitamin D Supplementation on Graves' Disease: The DAGMAR Trial.
PubMed
Journal
Thyroid
PubMed
Year
2023
PubMed
Publication types
Randomized Controlled Trial, Multicenter Study, Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
2.16
iCite
Revised in PubMed
2023-10-06
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grove-Laugesen DDianahttps://orcid.org/0000-0002-9681-7394
2Ebbehoj EEvahttps://orcid.org/0000-0001-7201-1268
3Watt TTorquilhttps://orcid.org/0000-0002-6001-7440
4Riis ALAnne Lene
5Østergård TTorbenhttps://orcid.org/0009-0009-5341-1501
6Bruun BJBjarke Johannessenhttps://orcid.org/0000-0002-9000-1722
7Juel Christiansen JJenshttps://orcid.org/0009-0002-9547-7364
8Hansen KWKlavs Würglerhttps://orcid.org/0000-0002-7452-2747
9Rejnmark LLarshttps://orcid.org/0000-0002-2152-4247

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Iodine RadioisotopesMajor topic
Graves DiseaseMajor topic
Adult
Pregnancy
Humans
Female
Male
Treatment Outcome
Antithyroid Agents
Vitamins
Dietary Supplements
Vitamin D
Recurrence

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02384668D-vitamin And Graves' Disease; Morbidity And Relapse ReductionDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42939785Vitamin D-VDR Signaling Across Thyroid Disorders: A Systematic Review of Molecular Mechanisms, Autoimmunity, Genetic Susceptibility, Experimental Evidence and Therapeutic Translation.Biomolecules2026https://conductscience.org/library/papers/42939785PubMed
42093983Vitamin D dynamics predict treatment response to intravenous glucocorticoids in thyroid-associated ophthalmopathy: a retrospective cohort study.Front Immunol2026https://conductscience.org/library/papers/42093983PubMed
41599829The Role of Vitamin D in Autoimmune Thyroid Diseases: From Immunomodulation to Clinical Implications.Nutrients2026https://conductscience.org/library/papers/41599829PubMed
41599655Vitamin D in Endocrine Disorders: A Broad Overview of Evidence in Musculoskeletal, Thyroid, Parathyroid, and Reproductive Disorders.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41599655PubMed
41585809Case Report: Resolution of complete heart block following vitamin D supplementation in a child with Graves disease.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/41585809PubMed
41395273Type 1 Diabetes Autoimmunity: To What Extent Vitamin D is Beneficial.Biochem Res Int2025https://conductscience.org/library/papers/41395273PubMed
41141249Vitamin D deficiency as a potential risk factor for thyroid cancer: a clinical perspective.Front Nutr2025https://conductscience.org/library/papers/41141249PubMed
40873557High-dose Vitamin D supplementation for immune recalibration in autoimmune diseases.Front Immunol2025https://conductscience.org/library/papers/40873557PubMed
40104316Effects of vitamin D replacement combined with Graves' disease therapy: a retrospective cohort study.Turk J Med Sci2025https://conductscience.org/library/papers/40104316PubMed
39264438Changes in bone density and microarchitecture following treatment of Graves' disease and the effects of vitamin D supplementation. A randomized clinical trial.Osteoporos Int2024https://conductscience.org/library/papers/39264438PubMed
38919472Association of circulating vitamin levels with thyroid diseases: a Mendelian randomization study.Front Endocrinol (Lausanne)2024https://conductscience.org/library/papers/38919472PubMed
38553734Enhanced predictive validity of integrative models for refractory hyperthyroidism considering baseline and early therapy characteristics: a prospective cohort study.J Transl Med2024https://conductscience.org/library/papers/38553734PubMed
38259461A Mendelian randomization study of the effect of serum 25-hydroxyvitamin D levels on autoimmune thyroid disease.Front Immunol2023https://conductscience.org/library/papers/38259461PubMed
38004154The 2023's Growing Evidence Confirming the Relationship between Vitamin D and Autoimmune Diseases.Nutrients2023https://conductscience.org/library/papers/38004154PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37218433

GET https://conductscience.org/api/papers/v1/37218433/authors